Drug General Information
Drug ID
D09GSV
Former ID
DIB009566
Drug Name
FBT-A05
Synonyms
Lymphomun; Bi-20; TPBs-05; Anti-CD20 bivalent monoclonal antibody (hematological cancer), Fresenius Biotech; Trifunctional antibody therapy (blood malignancy), Fresenius/Trion; Anti-CD20 bivalent monoclonal antibody (B-cell lymphoma, Triomab), Trion/Fresenius
Drug Type
Antibody
Indication Chronic lymphocytic leukaemia [ICD10:C91] Phase 1/2 [548949]
Company
TRION Pharma GmbH
Target and Pathway
Target(s) B-lymphocyte antigen CD20 Target Info [532416]
KEGG Pathway Hematopoietic cell lineage
References
Ref 548949Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800030721)
Ref 532416Immunotherapy with FBTA05 (Bi20), a trifunctional bispecific anti-CD3 x anti-CD20 antibody and donor lymphocyte infusion (DLI) in relapsed or refractory B-cell lymphoma after allogeneic stem cell transplantation: study protocol of an investigator-driven, open-label, non-randomized, uncontrolled, dose-escalating Phase I/II-trial. J Transl Med. 2013 Jul 2;11:160.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.